BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 22, 2026
Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
New compound, BioWorld Science RSS Feed RSS

Microscope with laptop displaying histology image.
Cancer

SJ-1461, a novel potent and orally bioavailable BET inhibitor

April 14, 2023
Researchers from University of Belgrade, St. Jude Children’s Research Hospital and affiliated organizations have provided details on the discovery of novel orally bioavailable BET inhibitors as potential anticancer drug candidates.
Read More
Cancer

Novel cannabinoid derivatives against pancreatic cancer disclosed

April 13, 2023
Pancreatic cancer is the third leading cause of cancer-related deaths with a 5-year survival rate of 11.5%. The toxicity and chemoresistance to...
Read More
Liver disease
Gastrointestinal

Novel quinazolinone-based COP1 modulators for NAFLD disclosed

April 12, 2023
Deregulation of enzymes that control lipid turnover such as adipose triglyceride lipase (ATGL) is an essential contributor to nonalcoholic fatty liver disease. Recent studies suggest that a fraction of the cytosolic pool of ATGL is proteasomal degraded by E3 ligase constitutive photomorphogenesis protein 1 (COP1).
Read More
Man scratching arm
Dermatologic

Mallinckrodt’s GRPR antagonists show promise for treating pruritus

April 11, 2023
To date, only one drug has been approved for the treatment of itch (persistent pruritus) and it only targets a small portion of the patient population. Researchers from Mallinckrodt plc have unveiled gastrin-releasing peptide receptor (GRPR) as an itch-specific receptor for nonhistaminergic itch.
Read More
Man piecing together a puzzle
Neurology/Psychiatric

DYR-684, a first-in-class DYRK1A/B PROTAC with promising pharmacokinetic profile

April 11, 2023
Researchers from the University of Arizona presented the discovery of first-in-class dual-specificity tyrosine phosphorylation-regulated kinase 1A/B (DYRK1A/B) proteolysis targeting chimeras (PROTACs) as potential Alzheimer’s disease (AD) therapeutic candidates.
Read More
Kidneys
Nephrology

IMG-025 ameliorates IgA nephropathy by inhibiting lectin-driven complement activation

April 6, 2023
Immunoglobulin A (IgA) nephropathy is the most prevalent glomerulonephritis worldwide that does not have a specific treatment. Its pathogenesis is complex and not well understood, but there is increasing evidence that the lectin-driven complement activation may be behind it. Mannose-binding lectin serine protease 2 (MASP-2) has been studied as a therapeutic target in the treatment of IgA nephropathy, as it is one of the main lectin pathway activators.
Read More
Cross section of brain
Neurology/Psychiatric

CVN-417, a nicotinic α6 receptor antagonist for Parkinson’s disease motor dysfunction disclosed

April 6, 2023
Parkinson’s disease (PD) is a neurodegenerative...
Read More
Brain and encephalography
Neurology/Psychiatric

Novel Kv7.2/3 activator ETX-123 disclosed by researchers from Eliem Therapeutics

April 3, 2023
First-generation Kv7.2/3 channel openers show significant efficacy but also display relevant...
Read More
Illustration of coronavirus blocked by the no symbol
Infection

Conjugates of NSAIDs and GS-441524 nucleotide analogue are efficacious against coronaviruses in vivo

March 16, 2023
Nucleoside or nucleotide antivirals are a common first-line treatment for viral diseases, acting as direct inhibitors of viral replication and transcription. The nucleoside GS-441524 and its prodrug remdesivir have shown broad-spectrum antiviral activity against several virus families, including Flaviviridae, Filoviridae, Pneumoviridae, paramyxoviruses and Coronaviridae.
Read More
Colorized transmission electron micrograph of SARS-CoV-2 (UK B.1.1.7 variant).
Infection

Researchers report discovery of TKB-245 and TKB-248, novel potent SARS-CoV-2 Mpro inhibitors

March 6, 2023
Researchers from the National Center for Global...
Read More
Previous 1 2 … 29 30 31 32 33 34 35 36 37 … 762 763 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 21, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing